ChemImage Wins $1 Million to Commercialize Its Filter Technology

ChemImage is one of six companies selected to receive up to $1 million in funding from the Ohio Third Frontier Advanced Materials Program, a program devoted to accelerating the development and growth of the advanced materials industry in Ohio. The award will be used to establish a manufacturing facility for its patented multi-conjugate filter (MCF) technology.

Based on liquid crystal technology, these unique tunable filters are the key component of the company’s hyperspectral imaging instrumentation used to characterize the material composition of samples crossing multiple industries.

“The assistance we receive from Ohio Third Frontier will be an important step in establishing ChemImage in an area of Ohio that’s well established in the liquid crystal community,” said Dr. Thomas Voigt, Executive Vice President of ChemImage & Head of Imaging Technology. “Our new manufacturing facility will make the best use of this knowledge that’s unique to Northeast Ohio, giving our company a competitive advantage in the diverse markets that we serve.”

ChemImage partnered with Kent State University’s Liquid Crystal Institute, the world’s first research center focused on the science of liquid crystals, when current liquid crystal vendors could not meet their technical requirements.

The Ohio Third Frontier Award will allow ChemImage to continue its collaboration with the Liquid Crystal Institute and establish a permanent manufacturing facility for ChemImage Imaging Technologies in Northeast Ohio, with about twenty jobs expected within the next two to five years of operation.

In addition to its Ohio expansion, ChemImage launched Gateway Analytical, an analytical testing company, last fall in Gibsonia, Pa. 

About ChemImage Corporation

ChemImage Corporation is a Pittsburgh based company committed to making the world healthier and safer through dramatic advancements in chemical imaging technology. The company combines proprietary, state-of-the-art imaging sensors, algorithms and analytical software to solve the world's most challenging health and safety issues.

ChemImage seeks to provide an Awareness of Things™ (AoT™) to a global audience, using the company's innovation platforms to provide people with unprecedented levels of vision, information and situational knowledge about their surroundings in their everyday lives. To accomplish this goal, the firm develops technologies for chemical and biological applications across many global industries; including life sciences, bio-medical, security, threat detection, anatomic pathology, forensics and diagnostics. 

For more information, contact ChemImage.